Citizens Business Bank Gsk PLC Transaction History

Citizens Business Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Nov 18, 2022	SELL	$42.0 - $48.25 $7,182 - $8,250	-171 Reduced 1.68%	10,000 $470,000
Q2 2019 Nov 18, 2022	BUY	$39.4 - $42.7 $6,737 - $7,301	171 Added 1.71%	10,171 $407,000
Q4 2018 Nov 18, 2022	SELL	$37.8 - $42.69 $15,119 - $17,076	-400 Reduced 3.85%	10,000 $382,000
Q2 2017 Nov 18, 2022	BUY	N/A	10,400 New	10,400 $448,000
Q4 2016 Nov 18, 2022	BUY	N/A	10,400	10,400 $400,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

Stay updated on Citizens Business Bank with notifications on news.